NAPSR-PHMSA Distribution Team Annual Update
NAPSR-PHMSA Distribution Team Annual Update
General
Legacy ID
21
Remarks of Deputy Administrator Tristan Brown Before PHMSA's Hazardous Materials Grants Conference
Tuesday, August 23, 2022 Tysons Corner, VAThank you Aaron. And let me begin by thanking Andre White, Bonita Brown, Matthew Hufford, Carla Sheppard, Flor Valencia, Lisa Reichenbacher, Suzette Edwards, and all of the other PHMSA team members who’ve worked so hard to put on this conference but...
Requisitos de Transporte de Materiales Peligrosos
Requisitos de Transporte de Materiales PeligrososNew Rule Strengthens Safety Requirements for more than 300,000 miles of Natural Gas Pipelines
PHMSA 07-22 Contact: PHMSA Public Affairs Email: phmsapublicaffairs@dot.gov
WASHINGTON – The U.S. Department of Transportation's Pipeline and Hazardous Materials Safety Administration (PHMSA) transmitted a final rule to the Federal Register today that will strengthen the safety and...
PHMSA Final Rule - Safety of Gas Transmission Pipelines: Repair Criteria, Integrity Management Improvements, Cathodic Protection, Management of Change, and Other Related Amendments
PHMSA issued the following Final Rule on August 4, 2022, and it has been submitted to the Office of the Federal Register for publication. Although PHMSA has taken steps to ensure the accuracy of this version of the Final Rule posted on the PHMSA website, and will post it in the docket (PHMSA-...
Improved Tools to Locate Buried Pipelines in a Congested Underground 693JK31810009
The project developed and validated a geospatial probe to map existing buried utilities through insertion into live gas pipelines. The resulting technology transfer led to the Live Gas Mapper (LGM-2) tool by REDUCT. The LGM-2 can map buried live gas pipes with an ID range of 50mm up to 100mm (2...
Safety Advisory Notice: Classification of MPXV Diagnostic Samples and Waste
The Safety Advisory Notice shares new advice from the Centers for Disease Control and Prevention (CDC) regarding diagnostic samples and clinical waste containing Monkeypox virus (MPXV) in Clade I or II. The advice clarifies that samples and clinical waste should be designated as Category B...